Mast Group Ltd
Nigel Thomas has a diverse and extensive work experience spanning over several companies in the healthcare and life sciences industries. Nigel most recently served as the Head of Sales and Marketing at Mast Group Ltd since July 2023. Prior to that, they were the General Manager at Novacyt Group from November 2021 to July 2023. Nigel also worked as the Sales Director EMEA at Quidel from May 2017 to November 2021. Before that, they held positions such as Business Manager at Agilent Technologies from July 2013 to May 2017, Sales Director Europe at Thermo Fisher Scientific from November 2010 to June 2013, and Leica Biosystems Business Manager at Leica Biosystems from January 2010 to November 2010. Nigel also worked at Leica Microsystems as the Regional Sales Manager - Clinical Microscopy from January 2008 to March 2010, Channel Sales Manager at Leica Biosystems from September 2005 to March 2008, Senior Account Executive at Ventana Medical Systems from March 1999 to September 2005, and Technical Sales Representative at Surgipath Europe Ltd from November 1997 to March 1999.
Nigel Thomas holds a Bachelor's degree in Biomedical Sciences, General from Cardiff University / Prifysgol Caerdydd.
Mast Group Ltd
1 followers
Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic). Mast Group were among the first companies to commercialise the antibiotic disc, and continue to work with major pharmaceutical companies worldwide in the development of new and exciting products. Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the investment in personnel, R&D and infrastructure, including state of the art manufacturing facilities in Merseyside. This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to develop products for the ever changing IVD market, creating solutions to support clinical diagnosis today and into the future.